{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:32:09Z","timestamp":1793241129730,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:00:00Z","timestamp":1793059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.addr.2026.115979","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:10:47Z","timestamp":1792451447000},"page":"115979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Bioorthogonal chemistry conjugates: ADCs and beyond"],"prefix":"10.1016","volume":"239","author":[{"given":"Bonnie","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn C.","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.addr.2026.115979_bb0005","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500262","article-title":"Linker design for the antibody drug conjugates: a comprehensive review","volume":"20","author":"Lei","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.addr.2026.115979_bb0010","article-title":"Rise of antibody-drug conjugates: the present and future","volume":"43","author":"Shastry","year":"2023","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"issue":"2","key":"10.1016\/j.addr.2026.115979_bb0015","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1021\/acs.bioconjchem.4c00398","article-title":"Modular synthesis of anti-HER2 dual-drug antibody-drug conjugates demonstrating improved toxicity","volume":"36","author":"Nervig","year":"2025","journal-title":"Bioconjug. Chem."},{"issue":"6 Pt 1","key":"10.1016\/j.addr.2026.115979_bb0020","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.biotechadv.2015.05.001","article-title":"Current methods for the synthesis of homogeneous antibody-drug conjugates","volume":"33","author":"Sochaj","year":"2015","journal-title":"Biotechnol. Adv."},{"issue":"2","key":"10.1016\/j.addr.2026.115979_bb0025","first-page":"157","article-title":"A review of conjugation technologies for antibody drug conjugates","volume":"8","author":"Fan","year":"2025","journal-title":"Antib. Ther."},{"issue":"1","key":"10.1016\/j.addr.2026.115979_bb0030","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1021\/acsptsci.3c00235","article-title":"In-depth structure and function characterization of heterogeneous interchain cysteine-conjugated antibody-drug conjugates","volume":"7","author":"Chen","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"1","key":"10.1016\/j.addr.2026.115979_bb0035","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1006\/abio.1994.1290","article-title":"A procedure for quantitative determination of tris(2-carboxyethyl)phosphine, an odorless reducing agent more stable and effective than dithiothreitol","volume":"220","author":"Han","year":"1994","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.addr.2026.115979_bb0040","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.elecom.2012.06.027","article-title":"Protein reducing agents dithiothreitol and tris(2-carboxyethyl)phosphine anodic oxidation","volume":"23","author":"Santarino","year":"2012","journal-title":"Electrochem. Commun."},{"issue":"Pt 2","key":"10.1016\/j.addr.2026.115979_bb0045","article-title":"High-payload trastuzumab-drug conjugates achieved through hydrophilic Y-shaped pendant PEG linkers for a potent and selective antitumor response","volume":"343","author":"Campara","year":"2026","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.addr.2026.115979_bb0050","series-title":"Strategic Applications of Named Reactions in Organic Synthesis : Background and Detailed Mechanisms","author":"K\u00fcrti","year":"2005"},{"issue":"18","key":"10.1016\/j.addr.2026.115979_bb0055","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1039\/C5PY00168D","article-title":"Thiol\u2013maleimide \u201cclick\u201d chemistry: evaluating the influence of solvent, initiator, and thiol on the reaction mechanism, kinetics, and selectivity","volume":"6","author":"Northrop","year":"2015","journal-title":"Polym. Chem."},{"issue":"16","key":"10.1016\/j.addr.2026.115979_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27165064","article-title":"Evidence of isomerization in the Michael-type thiol-maleimide addition: click reaction between L-cysteine and 6-maleimidehexanoic acid","volume":"27","author":"Nino-Ramirez","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.addr.2026.115979_bb0065","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1021\/cm402180t","article-title":"The Thiol-Michael addition click reaction: a powerful and widely used tool in materials chemistry","volume":"26","author":"Nair","year":"2014","journal-title":"Chem. Mater."},{"issue":"6","key":"10.1016\/j.addr.2026.115979_bb0070","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.xphs.2019.01.029","article-title":"Conjugation of emtansine onto trastuzumab promotes aggregation of the antibody-drug conjugate by reducing repulsive electrostatic interactions and increasing hydrophobic interactions","volume":"108","author":"Gandhi","year":"2019","journal-title":"J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.addr.2026.115979_bb0075","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.xphs.2023.12.003","article-title":"Agitation-induced aggregation of lysine- and interchain cysteine-linked antibody-drug conjugates","volume":"113","author":"Johann","year":"2024","journal-title":"J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.addr.2026.115979_bb0080","doi-asserted-by":"crossref","first-page":"942","DOI":"10.18632\/oncotarget.27512","article-title":"Correction: Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)","volume":"11","author":"Goldenberg","year":"2020","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.addr.2026.115979_bb0085","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1158\/1078-0432.CCR-16-1568","article-title":"ABBV-399, a c-met antibody-drug conjugate that targets both MET-amplified and c-met-overexpressing Tumors, irrespective of MET pathway dependence","volume":"23","author":"Wang","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"33","key":"10.1016\/j.addr.2026.115979_bb0090","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1200\/JCO.2018.78.7697","article-title":"First-in-human phase I, dose-escalation and -expansion study of telisotuzumab vedotin, an antibody-drug conjugate targeting c-met, in patients with advanced solid tumors","volume":"36","author":"Strickler","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.addr.2026.115979_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106982","article-title":"Click chemistry in the synthesis of antibody-drug conjugates","volume":"143","author":"Dudchak","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.addr.2026.115979_bb0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13045-022-01397-y","article-title":"Payload diversification: a key step in the development of antibody-drug conjugates","volume":"16","author":"Conilh","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.addr.2026.115979_bb0105","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1080\/10717544.2022.2039807","article-title":"Development of applicable thiol-linked antibody-drug conjugates with improved stability and therapeutic index","volume":"29","author":"Wang","year":"2022","journal-title":"Drug Deliv."},{"issue":"2","key":"10.1016\/j.addr.2026.115979_bb0110","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.2108","article-title":"Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates","volume":"30","author":"Shen","year":"2012","journal-title":"Nat. Biotechnol."},{"issue":"10","key":"10.1016\/j.addr.2026.115979_bb0115","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/nbt.2968","article-title":"Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates","volume":"32","author":"Lyon","year":"2014","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.addr.2026.115979_bb0120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1021\/bc5005262","article-title":"Long-term stabilization of maleimide-thiol conjugates","volume":"26","author":"Fontaine","year":"2015","journal-title":"Bioconjug. Chem."},{"issue":"2","key":"10.1016\/j.addr.2026.115979_bb0125","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1039\/D3MD00569K","article-title":"Linker substitution influences succinimide ring hydrolysis equilibrium impacting the stability of attachment to antibody-drug conjugates","volume":"15","author":"Wang","year":"2024","journal-title":"RSC Med. Chem."},{"issue":"Pt B","key":"10.1016\/j.addr.2026.115979_bb0130","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jconrel.2015.09.032","article-title":"Stabilization of cysteine-linked antibody drug conjugates with N-aryl maleimides","volume":"220","author":"Christie","year":"2015","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.addr.2026.115979_bb0135","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/anie.201508118","article-title":"Exocyclic olefinic maleimides: synthesis and application for stable and thiol-selective bioconjugation","volume":"55","author":"Kalia","year":"2016","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"28","key":"10.1016\/j.addr.2026.115979_bb0140","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.1002\/anie.201402606","article-title":"Preparation of well-defined antibody-drug conjugates through glycan remodeling and strain-promoted azide-alkyne cycloadditions","volume":"53","author":"Li","year":"2014","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"8","key":"10.1016\/j.addr.2026.115979_bb0145","doi-asserted-by":"crossref","first-page":"13459","DOI":"10.1021\/acsomega.5c10898","article-title":"Site-specific glycan conjugation improves stability and efficacy of an antibody-drug conjugates bearing DXd as a cytotoxic payload","volume":"11","author":"Manabe","year":"2026","journal-title":"ACS Omega"},{"issue":"6","key":"10.1016\/j.addr.2026.115979_bb0150","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1021\/bc400122c","article-title":"Enzyme-mediated methodology for the site-specific radiolabeling of antibodies based on catalyst-free click chemistry","volume":"24","author":"Zeglis","year":"2013","journal-title":"Bioconjug. Chem."},{"issue":"9","key":"10.1016\/j.addr.2026.115979_bb0155","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.str.2015.06.015","article-title":"The structural role of antibody N-glycosylation in receptor interactions","volume":"23","author":"Subedi","year":"2015","journal-title":"Structure"},{"key":"10.1016\/j.addr.2026.115979_bb0160","series-title":"GlyCLICK\u00ae: A Precise and Versatile Conjugation Platform for Improved Antibody-Drug Conjugates","year":"2026"},{"issue":"1","key":"10.1016\/j.addr.2026.115979_bb0165","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1039\/D4MD00637B","article-title":"Technical, preclinical, and clinical developments of Fc-glycan-specific antibody-drug conjugates","volume":"16","author":"Yang","year":"2025","journal-title":"RSC Med. Chem."},{"issue":"2","key":"10.1016\/j.addr.2026.115979_bb0170","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.apsb.2024.12.036","article-title":"Resistance to antibody-drug conjugates: a review","volume":"15","author":"Li","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"4","key":"10.1016\/j.addr.2026.115979_bb0175","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyag020","article-title":"Overcoming resistance to antibody-drug conjugates: mechanisms and emerging strategies","volume":"31","author":"Inase","year":"2026","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.addr.2026.115979_bb0180","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1158\/2159-8290.CD-21-0702","article-title":"Parallel genomic alterations of antigen and payload targets mediate polyclonal acquired clinical resistance to Sacituzumab Govitecan in triple-negative breast cancer","volume":"11","author":"Coates","year":"2021","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.addr.2026.115979_bb0185","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.addr.2026.115979_bb0190","doi-asserted-by":"crossref","first-page":"26881","DOI":"10.1038\/s41598-025-12725-w","article-title":"Therapeutic resistance and combination therapy for cancer: recent developments and future directions","volume":"15","author":"Damodaran","year":"2025","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.addr.2026.115979_bb0195","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/d41573-025-00121-y","article-title":"Dual-payload ADCs move into first oncology clinical trials","volume":"24","author":"Mullard","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.addr.2026.115979_bb0200","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1038\/ncomms7645","article-title":"A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy","volume":"6","author":"Maruani","year":"2015","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.addr.2026.115979_bb0205","article-title":"Site-specific modification of native IgGs with flexible drug-load","volume":"26","author":"Wehrmuller","year":"2025","journal-title":"Chembiochem"},{"issue":"9","key":"10.1016\/j.addr.2026.115979_bb0210","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1021\/acs.bioconjchem.9b00436","article-title":"A reactive antibody platform for one-step production of antibody-drug conjugates through a Diels-Alder reaction with maleimide","volume":"30","author":"St Amant","year":"2019","journal-title":"Bioconjug. Chem."},{"issue":"4","key":"10.1016\/j.addr.2026.115979_bb0215","doi-asserted-by":"crossref","DOI":"10.1148\/rycan.220157","article-title":"A review of theranostics: perspectives on emerging approaches and clinical advancements","volume":"5","author":"Burkett","year":"2023","journal-title":"Radiol. Imaging Cancer"},{"issue":"19","key":"10.1016\/j.addr.2026.115979_bb0220","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1002\/anie.200906294","article-title":"In vivo chemistry for pretargeted tumor imaging in live mice","volume":"49","author":"Rossin","year":"2010","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"33","key":"10.1016\/j.addr.2026.115979_bb0225","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adw1098","article-title":"Difluoroboronated tetrazine probes for rapid bioorthogonal fluorescence activation, no-wash STED imaging, and triggered drug release","volume":"11","author":"Zhu","year":"2025","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.addr.2026.115979_bb0230","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1039\/D0CS00556H","article-title":"Peptides as a platform for targeted therapeutics for cancer: peptide\u2013drug conjugates (PDCs)","volume":"50","author":"Cooper","year":"2021","journal-title":"Chem. Soc. Rev."},{"issue":"1","key":"10.1016\/j.addr.2026.115979_bb0235","article-title":"Modular synthesis of clickable peptides via late-stage maleimidation on C(7)-H tryptophan","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"issue":"17","key":"10.1016\/j.addr.2026.115979_bb0240","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1002\/ejoc.202100240","article-title":"RGD peptide-drug conjugates as effective dual targeting platforms: recent advances","volume":"2021","author":"Battistini","year":"2021","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.addr.2026.115979_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107292","article-title":"Advances in the pharmaceutical development of antibody-oligonucleotide conjugates","volume":"215","author":"Li","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"issue":"23","key":"10.1016\/j.addr.2026.115979_bb0250","doi-asserted-by":"crossref","first-page":"8982","DOI":"10.1039\/D4SC01838A","article-title":"Site-directed conjugation of single-stranded DNA to affinity proteins: quantifying the importance of conjugation strategy","volume":"15","author":"Rocha Tapia","year":"2024","journal-title":"Chem. Sci."},{"issue":"7","key":"10.1016\/j.addr.2026.115979_bb0255","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/cbic.202000727","article-title":"Site-specific antibody fragment conjugates for reversible staining in fluorescence microscopy","volume":"22","author":"Schwach","year":"2021","journal-title":"ChemBioChem"},{"issue":"1","key":"10.1016\/j.addr.2026.115979_bb0260","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1021\/acs.bioconjchem.5b00613","article-title":"Simple method to prepare oligonucleotide-conjugated antibodies and its application in multiplex protein detection in single cells","volume":"27","author":"Gong","year":"2016","journal-title":"Bioconjug. Chem."},{"issue":"1","key":"10.1016\/j.addr.2026.115979_bb0265","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/s41598-020-58238-6","article-title":"Preparation of single- and double-oligonucleotide antibody conjugates and their application for protein analytics","volume":"10","author":"Wiener","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.addr.2026.115979_bb0270","doi-asserted-by":"crossref","first-page":"23844","DOI":"10.1038\/s41598-021-03135-9","article-title":"Oligonucleotide conjugated antibody strategies for cyclic immunostaining","volume":"11","author":"Jones","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2026.115979_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120940","article-title":"Antibody-siRNA conjugates (ARCs) using multifunctional peptide as a tumor enzyme cleavable linker mediated effective intracellular delivery of siRNA","volume":"606","author":"Yu","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.addr.2026.115979_bb0280","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10040838","article-title":"Antibody-oligonucleotide conjugates: a twist to antibody-drug conjugates","volume":"10","author":"Dugal-Tessier","year":"2021","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.addr.2026.115979_bb0285","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3724\/abbs.2025212","article-title":"Antibody-oligonucleotide conjugates for spatial proteomics: principles, applications, and challenges","volume":"58","author":"Qiu","year":"2025","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"6","key":"10.1016\/j.addr.2026.115979_bb0290","article-title":"Efficiency landscape of bioorthogonal click reactions producing bispecific antibody conjugates","volume":"6","author":"Petri","year":"2026","journal-title":"Cell Rep. Methods"},{"issue":"12","key":"10.1016\/j.addr.2026.115979_bb0295","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.it.2012.07.007","article-title":"Application of IL-2 therapy to target T regulatory cell function","volume":"33","author":"Shevach","year":"2012","journal-title":"Trends Immunol."},{"issue":"9","key":"10.1016\/j.addr.2026.115979_bb0300","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202300115","article-title":"Generation of IL-2-Fc-antibody conjugates by click chemistry","volume":"18","author":"Williams","year":"2023","journal-title":"Biotechnol. J."},{"issue":"47","key":"10.1016\/j.addr.2026.115979_bb0305","doi-asserted-by":"crossref","first-page":"16820","DOI":"10.1073\/pnas.1408605111","article-title":"Bispecific antibody generated with sortase and click chemistry has broad antiinfluenza virus activity","volume":"111","author":"Wagner","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.addr.2026.115979_bb0310","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1021\/acsmedchemlett.3c00414","article-title":"Bispecific antibodies produced via chemical site-specific conjugation technology: AJICAP second-generation","volume":"14","author":"Fujii","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.addr.2026.115979_bb0315","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1021\/acs.bioconjchem.0c00002","article-title":"A plug-and-play approach for the de novo generation of dually functionalized bispecifics","volume":"31","author":"Maruani","year":"2020","journal-title":"Bioconjug. Chem."},{"issue":"5460","key":"10.1016\/j.addr.2026.115979_bb0320","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1126\/science.287.5460.2007","article-title":"Cell surface engineering by a modified Staudinger reaction","volume":"287","author":"Saxon","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.addr.2026.115979_bb0325","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jconrel.2020.12.002","article-title":"In vivo tracking of bioorthogonally labeled T-cells for predicting therapeutic efficacy of adoptive T-cell therapy","volume":"329","author":"Kim","year":"2021","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.addr.2026.115979_bb0330","first-page":"951","article-title":"Click CAR-T cell engineering for robustly boosting cell immunotherapy in blood and subcutaneous xenograft tumor","volume":"6","author":"Pan","year":"2021","journal-title":"Bioact. Mater."},{"issue":"48","key":"10.1016\/j.addr.2026.115979_bb0335","doi-asserted-by":"crossref","first-page":"23047","DOI":"10.1039\/D5SC05541E","article-title":"Efficient and rapid cell surface functionalization: a sub-minute selenol-yne click reaction for bioconjugation","volume":"16","author":"Shan","year":"2025","journal-title":"Chem. Sci."},{"issue":"1","key":"10.1016\/j.addr.2026.115979_bb0340","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1038\/s41467-022-33854-0","article-title":"Cell-specific bioorthogonal tagging of glycoproteins","volume":"13","author":"Cioce","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115979_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2025.118557","article-title":"Bioorthogonal chemistry-triggered engineering on cell membrane for precise bioimaging in living organisms","volume":"195","author":"Ma","year":"2026","journal-title":"TrAC Trends Anal. Chem."},{"issue":"7","key":"10.1016\/j.addr.2026.115979_bb0350","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-026-03503-6","article-title":"Regulatory and quality considerations of antibody-drug conjugates","volume":"27","author":"Cha","year":"2026","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"10.1016\/j.addr.2026.115979_bb0355","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41571-023-00850-2","article-title":"Exploring the next generation of antibody-drug conjugates","volume":"21","author":"Tsuchikama","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.addr.2026.115979_bb0360","doi-asserted-by":"crossref","DOI":"10.1002\/jcph.70166","article-title":"Learnings from approved antibody-drug conjugates: clinical pharmacology perspectives","volume":"66","author":"Thalluri","year":"2026","journal-title":"J. Clin. Pharmacol."},{"issue":"12","key":"10.1016\/j.addr.2026.115979_bb0365","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/s41573-024-01051-x","article-title":"Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeutics","volume":"23","author":"Carter","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.addr.2026.115979_bb0370","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/s41568-025-00869-w","article-title":"Unveiling the molecular and immunological drivers of antibody-drug conjugates in cancer treatment","volume":"25","author":"Zippelius","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.addr.2026.115979_bb0375","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41578-024-00725-7","article-title":"CRISPR\u2013Cas9 delivery strategies for the modulation of immune and non-immune cells","volume":"10","author":"Alsaiari","year":"2025","journal-title":"Nat. Rev. Mater."},{"issue":"34","key":"10.1016\/j.addr.2026.115979_bb0380","article-title":"Cell surface engineering tools for programming living assemblies","volume":"10","author":"Almeida-Pinto","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.addr.2026.115979_bb0385","doi-asserted-by":"crossref","DOI":"10.1038\/s41434-026-00621-5","article-title":"Research progress and development strategies of antibody-oligonucleotide conjugates","author":"Fan","year":"2026","journal-title":"Gene Ther."},{"issue":"22","key":"10.1016\/j.addr.2026.115979_bb0390","doi-asserted-by":"crossref","first-page":"7737","DOI":"10.1039\/D2CS00889K","article-title":"Bioorthogonal chemistry for prodrug activation in vivo","volume":"52","author":"Fu","year":"2023","journal-title":"Chem. Soc. Rev."},{"issue":"2","key":"10.1016\/j.addr.2026.115979_bb0395","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s41061-025-00495-y","article-title":"Toward realization of bioorthogonal chemistry in the clinic","volume":"383","author":"de Roode","year":"2025","journal-title":"Top. Curr. Chem. (Cham)"},{"issue":"1","key":"10.1016\/j.addr.2026.115979_bb0400","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41698-025-01159-2","article-title":"Leveraging artificial intelligence in antibody-drug conjugate development: from target identification to clinical translation in oncology","volume":"9","author":"Lu","year":"2025","journal-title":"npj Precis. Oncol."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X26002139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X26002139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:55:14Z","timestamp":1793238914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X26002139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":80,"alternative-id":["S0169409X26002139"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2026.115979","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioorthogonal chemistry conjugates: ADCs and beyond","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2026.115979","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115979"}}